Novonesis (Novozymes) A/S
The answer first
Does Novonesis (Novozymes) beat the market?
Yes, Novonesis (Novozymes) has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 77% of Nordic stocks
- Quality91
- Value21
- Trend80
No. 21 of 71 in basic materials
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash Novonesis (Novozymes) keeps must grow about 15% a year for 10 years.
Max for seven days
Follow Novonesis (Novozymes) with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Novonesis (Novozymes)
Your first answer is free, no account needed.
Do you own Novonesis (Novozymes), or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Novonesis (Novozymes) and a few more. Free, no card.
Super Stock+45.4%In short
- Novonesis (Novozymes) has risen 13.8% over the past year, including dividends.
- Overall, Novonesis (Novozymes) ranks better than 77% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 32.5%. The price is 10.3% below its peak now.
What do analysts think of Novonesis (Novozymes)?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 77% of Nordic stocks.
No. 21 of 71 in basic materials
High A solid company: it earns well on its money and has healthy finances.
No. 5 of 72 in basic materialsTypical in basic materials: 65Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.31
- Asset turnoverSales divided by everything the company owns0.26
- Return on equityProfit divided by equity+6.1%
- Cash conversionOperating cash flow divided by profit1.80
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 57 of 71 in basic materialsTypical in basic materials: 59Typical in the Nordics: 50
- P/BPrice divided by equity2.4
- P/SPrice divided by sales6.2
- P/EPrice divided by earnings39.5
- P/CFPrice divided by operating cash flow21.9
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 7 of 72 in basic materialsTypical in basic materials: 36Typical in the Nordics: 50
- 3 months−1.5%
- 6 months+17.2%
- 9 months+16.4%
- 12 months+13.8%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Novonesis (Novozymes)
67 funds we follow own Novonesis (Novozymes). The share is how much of the fund the stock makes up.
- Norway6
- Sweden52
- Denmark9
- 3 ETFs
- Sparindex INDEX OMX C25 KLDenmark · Sparindex7.9%
- Sparinvest INDEX OMX C25 KLDenmark · Sparinvest7.9%
- Xact KapitalforvaltningDenmark · XACT · ETF7.3%
- Nordnet Indeksfond Danmark ASweden · Nordnet7.3%
- Sydinv Indeks Danmark A DKKDenmark · Sydinvest6.2%
- BIX Danske Aktier Indeks ADenmark · BIX4.5%
- BIX Danske Aktier Indeks Akk ADenmark · BIX4.5%
- Danske Invest Danmark IndeksDenmark · Danske Invest4.5%
Show all 67
- Lannebo Norden BSweden · Lannebo2.8%
- Lannebo Norden Hållbar SEKSweden · Lannebo2.8%
- Wealth Inv I&T Nord AktLargeCaDenmark · Wealth Invest2.1%
- Heimdal Norden Utbytte ANorway · Heimdal1.8%
- Xact NordenSweden · XACT · ETF1.8%
- Levler MSCI Nordic by Xtrackers UCITS ETFSweden · Levler · ETF1.8%
- Alfred Berg Nordic Index R (SEK)Norway · Alfred Berg1.7%
- DNB Norden Indeks ANorway · DNB1.7%
- Nordea AlfaSweden · Nordea1.6%
- Nordea OlympiafondSweden · Nordea1.5%
- KLP AksjeNorden IndeksNorway · KLP1.5%
- Fondsfinans Norden BNorway · Fondsfinans1.4%
- Handelsbanken Global Dynam 90 (A1 SEK)Sweden · Handelsbanken1.3%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken1.3%
- SPP Global Solutions ASweden · SPP1.1%
- AMF Aktiefond EuropaSweden · AMF1.1%
- Handelsbanken Nordenfond (A1 NOK)Sweden · Handelsbanken0.9%
- SPP Europa Plus ASweden · SPP0.8%
- Skandia Världen SverigeSweden · Skandia0.7%
- Avanza EuropaSweden · Avanza0.7%
- Folksam LO VärldenSweden · Folksam0.6%
- Swedbank Robur Access Edge Europe ASweden · Swedbank Robur0.5%
- Swedbank HumanfondSweden · Swedbank Robur0.4%
- Vibrand Norden ANorway · Vibrand0.3%
- Swedbank Robur Access Europa ASweden · Swedbank Robur0.3%
- KPA Etisk AktiefondSweden · KPA0.3%
- Skandia Europa ExponeringSweden · Skandia0.2%
- Havsfonden BSweden · Havsfonden0.2%
- SEB Europe Exposure B (SEK)Sweden · SEB0.2%
- Länsförsäkringar Europa IndexnäraSweden · Länsförsäkringar0.2%
- SPP Global Plus ASweden · SPP0.2%
- Öhman Etisk Index EuropaSweden · Öhman0.2%
- SPP Aktiefond EuropaSweden · SPP0.1%
- Storebrand Europa C NOKSweden · Storebrand0.1%
- GodFond Sverige & VärldenSweden · GodFond0.1%
- Länsförsäkringar MultistrategiSweden · Länsförsäkringar0.1%
- Nordea Inst Aktie VärldenSweden · Nordea0.1%
- SEB Active 80 ASweden · SEB0.1%
- Wealth Invest SGA Globale AktDenmark · Wealth Invest0.1%
- Handelsbanken Developed Markets Index Criteria (A1 SEK)Sweden · Handelsbanken0.1%
- Lysa Global Aktier Hållbar BSweden · Lysa0.1%
- Länsförsäkringar Global KlimatIndexSweden · Länsförsäkringar0.1%
- SEB Active 55 ASweden · SEB0.1%
- Avanza GlobalSweden · Avanza0.1%
- AP7 AktiefondSweden · AP70.0%
- Handelsbanken Global Index Crit (A1 NOK)Sweden · Handelsbanken0.0%
- Nordea Donationsmedelsfond utdSweden · Nordea0.0%
- Handelsbanken Global Index Core (A1 SEK)Sweden · Handelsbanken0.0%
- Lysa Aktier CSweden · Lysa0.0%
- Länsförsäkringar Global IndexnäraSweden · Länsförsäkringar0.0%
- SEB Active 30 ASweden · SEB0.0%
- Skandia Global Exponering ASweden · Skandia0.0%
- Öhman Global Marknad Hållbar ASweden · Öhman0.0%
- PLUS Global IndexSweden · PLUS0.0%
- SEB Active 20 ASweden · SEB0.0%
- SEB Dynamisk AktiefondSweden · SEB0.0%
- Swedbank Robur Access Global ASweden · Swedbank Robur0.0%
- Länsförsäkringar Sparmål 2030Sweden · Länsförsäkringar0.0%
- Skandia SMART FörsiktigSweden · Skandia0.0%
From the funds' latest known holdings.
About Novonesis (Novozymes)
Novonesis (Novozymes) A/S is a company in basic materials, listed on Nasdaq Copenhagen. By market value, Novonesis (Novozymes) is the largest of 7 companies in basic materials on Nasdaq Copenhagen. Dividends over the past twelve months equal 1.5% of the share price. Of the three measures in the ranking, Novonesis (Novozymes) is strongest on quality, better than 91% of Nordic stocks. The next report from Novonesis (Novozymes) is expected on 24 February 2027. The share trades in DKK. It has around 11,000 employees.
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel.


See the full analysis of Novonesis (Novozymes).
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card